Mucormycosis is a difficult to diagnose rare disease with high morbidity and mortality.
Diagnosis is often delayed, and disease tends to progress rapidly. Urgent surgical and …

Mucormycosis is an infection caused by a group of filamentous molds within the order
Mucorales. Infections may result from ingestion of contaminated food, inhalation of spores …

Invasive mucormycosis is a life-threatening fungal infection that most frequently occurs in
patients with underlying comorbidities impacting immune system function. 1–4 Rhino-orbital …

Abstract These European Society for Clinical Microbiology and Infectious Diseases and
European Confederation of Medical Mycology Joint Clinical Guidelines focus on the …

Posaconazole is typically used for preventing invasive yeast and mold infections such as
invasive aspergillosis in high-risk immunocompromised patients. The oral suspension was …

Mucormycosis is a deadly opportunistic disease caused by a group of fungus named
mucormycetes. Fungal spores are normally present in the environment and the immune …

Invasive fungal infections remain a major cause of morbidity and mortality in
immunocompromised patients, and such infections are a substantial burden to healthcare …

Mucormycosis (MCR) is an emerging and frequently lethal fungal infection caused by the
Mucorales family, with Rhizopus, Mucor, and Lichtheimia, accounting for> 90% of all cases …

Posaconazole is a second-generation triazole agent with a potent and broad antifungal
activity. In addition to the oral suspension, a delayed-release tablet and intravenous …

Mucormycosis represents the third most common invasive fungal infection in children, and
recent studies have suggested a rising incidence. Its case fatality rate is high, especially for …